Moleculin Biotech
MBRX
MBRX
18 hedge funds and large institutions have $2.3M invested in Moleculin Biotech in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$205K | |
| 2 | +$89K | |
| 3 | +$72.6K | |
| 4 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$52.6K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$24K |
Top Sellers
| 1 | -$24K | |
| 2 | -$9K | |
| 3 | -$6K | |
| 4 |
GRP
Global Retirement Partners
San Rafael,
California
|
-$1K |